Benzinga's Top #PreMarket Gainers By: Benzinga via Benzinga September 24, 2015 at 08:08 AM EDT Conatus Pharmaceuticals Inc (NASDAQ: CNAT) shares rose 25.44 percent to $7.20 in pre-market trading after the company reported ... Read More >> Related Stocks: Conatus Pharmaceutic Keryx Biopharm Inc Micron Technology